Latus Bio to Present Gene Therapy Data at ASGCT
PHILADELPHIA, PA — Latus Bio said it will present new preclinical and computational data related to experimental gene therapies for Huntington’s disease and CLN2 disease at the ASGCT 2026 Annual …
Latus Bio to Present Gene Therapy Data at ASGCT Read More